{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:44:54Z","timestamp":1792593894723,"version":"4.5.0"},"reference-count":38,"publisher":"MyJove Corporation","issue":"223","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68500","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:00:45Z","timestamp":1758322845000},"source":"Crossref","is-referenced-by-count":1,"title":["Detection of <em>Mycoplasma pneumoniae<\/em> Nucleic Acid and Drug Resistance Gene"],"prefix":"10.3791","author":[{"given":"Yunxia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","type":"journal-article","article-title":"Mycoplasma pneumoniae from the Respiratory Tract and Beyond","volume":"30","author":"Waites","year":"2017","unstructured":"Waites, K. B., Xiao, L., Liu, Y., Balish, M. F., Atkinson, T. P. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 30 (3),747-809 (2017).","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"e00242","DOI":"10.1128\/JCM.00242-20","type":"journal-article","article-title":"Evaluation of Commercial Molecular Diagnostic Methods for Detection and Determination of Macrolide Resistance in Mycoplasma pneumoniae","volume":"58","author":"Leal","year":"2020","unstructured":"Leal, S. M. Jr. et al. Evaluation of Commercial Molecular Diagnostic Methods for Detection and Determination of Macrolide Resistance in Mycoplasma pneumoniae. J Clin Microbiol. 58 (6), e00242-20 (2020).","journal-title":"J Clin Microbiol"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/ppul.21481","type":"journal-article","article-title":"Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid","volume":"46","author":"Lu","year":"2011","unstructured":"Lu, A., Wang, L., Zhang, X., Zhang, M. Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid. Pediatr Pulmonol. 46 (11), 1093-1097 (2011).","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"ref4","first-page":"306","type":"journal-article","article-title":"Mycoplasma pneumoniae infection and drug resistance in children in Meizhou area from 2010 to 2014","volume":"32","author":"Li","year":"2016","unstructured":"Li, Z. W. et al. Mycoplasma pneumoniae infection and drug resistance in children in Meizhou area from 2010 to 2014. Chinese J Zoonoses. 32 (3), 306-311 (2016).","journal-title":"Chinese J Zoonoses"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"e0173635","DOI":"10.1371\/journal.pone.0173635","type":"journal-article","article-title":"Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"12","author":"Ishiguro","year":"2017","unstructured":"Ishiguro, N. et al. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. PLoS One. 12 (3), e0173635(2017).","journal-title":"PLoS One"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0970-2113.63611","type":"journal-article","article-title":"Mycoplasma pneumonia: Clinical features and management","volume":"27","author":"Kashyap","year":"2010","unstructured":"Kashyap, S., Sarkar, M. Mycoplasma pneumonia: Clinical features and management. Lung India. 27 (2), 75-85 (2010).","journal-title":"Lung India"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jiac.2015.02.007","type":"journal-article","article-title":"Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: Comparison with real-time PCR","volume":"21","author":"Miyashita","year":"2015","unstructured":"Miyashita, N. et al. Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: Comparison with real-time PCR. J Infect Chemother. 21 (6), 473-475 (2015).","journal-title":"J Infect Chemother"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"2100129","DOI":"10.1183\/13993003.00129-2021","type":"journal-article","article-title":"Mycoplasma pneumoniae carriage evades induction of protective mucosal antibodies","volume":"59","author":"de Groot","year":"2022","unstructured":"de Groot, R. C. A. et al. Mycoplasma pneumoniae carriage evades induction of protective mucosal antibodies. Eur Respir J. 59 (4), 2100129 (2022).","journal-title":"Eur Respir J"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.23736\/S0026-4946.16.04866-0","type":"journal-article","article-title":"Diagnosis and treatment of Mycoplasma pneumoniae in children","volume":"69","author":"Rogozinski","year":"2017","unstructured":"Rogozinski, L. E., Alverson, B. K., Biondi, E. A. Diagnosis and treatment of Mycoplasma pneumoniae in children. Minerva Pediatr. 69 (2), 156-160 (2017).","journal-title":"Minerva Pediatr"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.medmal.2016.12.002","type":"journal-article","article-title":"Prevalence of Chlamydophila pneumoniae and Mycoplasma pneumoniae IgM and IgG antibodies in Tunisian patients presenting with exacerbation of chronic obstructive pulmonary disease","volume":"47","author":"Messous","year":"2017","unstructured":"Messous, S. et al. Prevalence of Chlamydophila pneumoniae and Mycoplasma pneumoniae IgM and IgG antibodies in Tunisian patients presenting with exacerbation of chronic obstructive pulmonary disease. Med Mal Infect. 47 (2), 158-163 (2017).","journal-title":"Med Mal Infect"},{"issue":"09","key":"ref11","first-page":"841","type":"journal-article","article-title":"Research progress on laboratory detection technology of Mycoplasma pneumoniae","volume":"33","author":"Li","year":"2017","unstructured":"Li, Q. Z., Shi, W. Y., Chen, H. L. Research progress on laboratory detection technology of Mycoplasma pneumoniae. Chinese J Zoonoses. 33 (09), 841-844 (2017).","journal-title":"Chinese J Zoonoses"},{"issue":"2","key":"ref12","first-page":"127","type":"journal-article","article-title":"Comparison of PCR and RT-PCR detection of Mycoplasma pneumoniae in throat swab specimens","volume":"28","author":"Li","year":"2012","unstructured":"Li, C. et al.Comparison of PCR and RT-PCR detection of Mycoplasma pneumoniae in throat swab specimens. Chinese J Zoonoses. 28 (2),127-130 (2012).","journal-title":"Chinese J Zoonoses"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tibtech.2018.12.002","type":"journal-article","article-title":"The Ultimate qPCR Experiment: Producing Publication Quality, Reproducible Data the First Time","volume":"37","author":"Taylor","year":"2019","unstructured":"Taylor, S. C. et al. The Ultimate qPCR Experiment: Producing Publication Quality, Reproducible Data the First Time. Trends Biotechnol. 37 (7), 761-774 (2019).","journal-title":"Trends Biotechnol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","type":"journal-article","article-title":"Mycoplasma pneumoniae and its role as a human pathogen","volume":"17","author":"Waites","year":"2004","unstructured":"Waites, K. B., Talkington, D. F. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 17 (4), 697-728 (2004).","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/crj.12379","type":"journal-article","article-title":"Overview of antimicrobial options for Mycoplasma pneumoniae: focus on macrolide resistance","volume":"11","author":"Cao","year":"2017","unstructured":"Cao, B., Qu, J. X., Yin, Y. D., Eldere, J. V. Overview of antimicrobial options for Mycoplasma pneumoniae: focus on macrolide resistance. Clin Respir J. 11 (4), 419-429 (2017).","journal-title":"Clin Respir J"},{"key":"ref16","first-page":"320801","type":"journal-article","article-title":"Drug resistance mechanisms of Mycoplasma pneumoniae to macrolide antibiotics","volume":"2014","author":"Liu","year":"2014","unstructured":"Liu, X. et al. Drug resistance mechanisms of Mycoplasma pneumoniae to macrolide antibiotics. Biomed Res Int. 2014, 320801 (2014).","journal-title":"Biomed Res Int"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1309\/LMYEY7P26RHWRRUL","type":"journal-article","article-title":"Mycoplasma pneumoniae 23S rRNA Gene Mutations and Mechanisms of Macrolide Resistance","volume":"44","author":"Ye","year":"2013","unstructured":"Ye, Y., Li, S., Li, Y., Ren, T., Liu, K. Mycoplasma pneumoniae 23S rRNA Gene Mutations and Mechanisms of Macrolide Resistance. Lab Med. 44 (1), 63-68 (2013).","journal-title":"Lab Med"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"e0198557","DOI":"10.1371\/journal.pone.0198557","type":"journal-article","article-title":"Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China","volume":"13","author":"Xue","year":"2018","unstructured":"Xue, G. et al. Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China. PLoS One. 13 (8), e0198557 (2018).","journal-title":"PLoS One"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"E212","DOI":"10.1111\/1469-0691.12107","type":"journal-article","article-title":"The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains","volume":"19","author":"Pereyre","year":"2013","unstructured":"Pereyre, S. et al. The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains. Clin Microbiol Infect. 19 (4), E212-E217 (2013).","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1469-0691.2009.02968.x","type":"journal-article","article-title":"Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany","volume":"16","author":"Dumke","year":"2010","unstructured":"Dumke, R., von Baum, H., L\u00fcck, P. C., Jacobs, E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 16 (6), 613-616 (2010).","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/INF.0b013e318247f3e0","type":"journal-article","article-title":"Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States","volume":"31","author":"Yamada","year":"2012","unstructured":"Yamada, M., Buller, R., Bledsoe, S., Storch, G. A. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J. 31 (4), 409-500 (2012).","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"ref22","first-page":"20073","type":"journal-article","article-title":"Epidemic of Mycoplasma pneumoniae infection in in Denmark, 2010 and 2011","volume":"17","author":"Uldum","year":"2010","unstructured":"Uldum, S. A. et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 17 (5), 20073 (2012).","journal-title":"Euro Surveill"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3201\/eid1909.121466","type":"journal-article","article-title":"Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011","volume":"19","author":"Eshaghi","year":"2013","unstructured":"Eshaghi, A. et al. Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011. Emerg Infect Dis. 19 (9), 1525-1527 (2013).","journal-title":"Emerg Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7168949","DOI":"10.1155\/2019\/7168949","type":"journal-article","article-title":"First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy","volume":"2019","author":"Loconsole","year":"2019","unstructured":"Loconsole, D. et al. First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy. Biomed Res Int. 2019, 7168949 (2019).","journal-title":"Biomed Res Int"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"e38585","DOI":"10.1371\/journal.pone.0038585","type":"journal-article","article-title":"The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel","volume":"7","author":"Pereyre","year":"2012","unstructured":"Pereyre, S. et al. The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One. 7 (6), e38585 (2012).","journal-title":"PLoS One"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/jac\/dkaa256","type":"journal-article","article-title":"Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain","volume":"75","author":"Rivaya","year":"2020","unstructured":"Rivaya, B. et al. Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain. J Antimicrob Chemother. 75 (10), 2752-2759 (2020).","journal-title":"J Antimicrob Chemother"},{"issue":"48","key":"ref27","doi-asserted-by":"crossref","first-page":"30078","DOI":"10.2807\/1560-7917.ES.2015.20.48.30078","type":"journal-article","article-title":"Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015","volume":"20","author":"Brown","year":"2015","unstructured":"Brown, R. J., Macfarlane-Smith, L., Phillips, S., Chalker, V. J. Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. Euro Surveill. 20 (48), 30078 (2015).","journal-title":"Euro Surveill"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.11150\/kansenshogakuzasshi.89.16","type":"journal-article","article-title":"Gene Mutations Associated with Macrolide-resistance and p1 Gene Typing of Mycoplasma pneumoniae Isolated in Yamagata, Japan, between 2004 and 2013","volume":"89","author":"Suzuki","year":"2015","unstructured":"Suzuki, Y. et al. Gene Mutations Associated with Macrolide-resistance and p1 Gene Typing of Mycoplasma pneumoniae Isolated in Yamagata, Japan, between 2004 and 2013. Kansenshogaku Zasshi. 89 (1), 16-22 (2015).","journal-title":"Kansenshogaku Zasshi"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1128\/AAC.00663-13","type":"journal-article","article-title":"Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients","volume":"57","author":"Kawai","year":"2013","unstructured":"Kawai, Y. et al. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother. 57 (8), 4046-4049 (2013).","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref30","first-page":"11","type":"journal-article","article-title":"Analysis on Mycoplasma pneumonia 23SrRNA gene mutation site and drug resistance phenotype","volume":"28","author":"Yun","year":"2013","unstructured":"Yun, Y. E. et al. Analysis on Mycoplasma pneumonia 23SrRNA gene mutation site and drug resistance phenotype. Lab Med. 28 (1), 11-16 (2013).","journal-title":"Lab Med"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","type":"journal-article","article-title":"Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia","volume":"16","author":"Morozumi","year":"2010","unstructured":"Morozumi, M., Takahashi, T., Ubukata, K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 16 (2), 78-86 (2010).","journal-title":"J Infect Chemother"},{"key":"ref32","type":"book","volume-title":"Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline","author":"Waites","year":"2011","unstructured":"Waites, K. B. et al. Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline. Wayne (PA): Clinical and Laboratory Standards Institute. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544375\/ (2011)."},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","type":"journal-article","article-title":"Mycoplasma pneumoniae from the Respiratory Tract and Beyond","volume":"30","author":"Waites","year":"2017","unstructured":"Waites, K. B., Xiao, L., Liu, Y., Balish, M. F., Atkinson, T. P. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 30 (3), 747-809 (2017).","journal-title":"Clin Microbiol Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fmicb.2016.00232","type":"journal-article","article-title":"The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae","volume":"7","author":"Diaz","year":"2016","unstructured":"Diaz, M. H., Winchell, J. M. The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae. Front Microbiol. 7, 232(2016).","journal-title":"Front Microbiol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/JCM.38.3.965-970.2000","type":"journal-article","article-title":"Genotyping of Mycoplasma pneumoniae clinical isolates reveals eight P1 subtypes within two genomic groups","volume":"38","author":"Dorigo-Zetsma","year":"2000","unstructured":"Dorigo-Zetsma, J. W., Dankert, J., Zaat, S. A. Genotyping of Mycoplasma pneumoniae clinical isolates reveals eight P1 subtypes within two genomic groups. J Clin Microbiol. 38 (3), 965-970 (2000).","journal-title":"J Clin Microbiol"},{"issue":"20","key":"ref36","first-page":"4782","type":"journal-article","article-title":"Research progress on drug resistance mechanism of Mycoplasma pneumoniae","volume":"26","author":"Guo","year":"2016","unstructured":"Guo, Y. et al. Research progress on drug resistance mechanism of Mycoplasma pneumoniae. Chinese J Nosocomial Infect. 26 (20), 4782-4784 (2016).","journal-title":"Chinese J Nosocomial Infect"},{"issue":"11","key":"ref37","first-page":"1176","type":"journal-article","article-title":"Mutation analysis and clinical significance of multidrug resistance gene loci in children with Mycoplasma pneumoniae","volume":"26","author":"Zhang","year":"2024","unstructured":"Zhang, W., Wang, Y., Cai, L. J. Mutation analysis and clinical significance of multidrug resistance gene loci in children with Mycoplasma pneumoniae. Chinese J Cont Pediat. 26 (11), 1176-1181 (2024).","journal-title":"Chinese J Cont Pediat"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","type":"journal-article","article-title":"Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment","volume":"7","author":"Pereyre","year":"2016","unstructured":"Pereyre, S., Goret, J., B\u00e9b\u00e9ar, C. Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment. Front Microbiol. 7, 974 (2016).","journal-title":"Front Microbiol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68500\/detection-mycoplasma-pneumoniae-nucleic-acid-drug-resistance","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:30:41Z","timestamp":1792593041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68500\/detection-mycoplasma-pneumoniae-nucleic-acid-drug-resistance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":38,"journal-issue":{"issue":"223","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68500","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}